Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
Publication date
2022-02-09
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Introduction: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. Methodology: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. Results: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. Discussion: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival.
Keywords
cancer immunity, chromosomal instability disorders, mutation–genetics, neoantigen and shared-antigen vaccine, pancreatic cancer, General Medicine
Citation
Levink, I J M, Brosens, L A A, Rensen, S S, Aberle, M R, Olde Damink, S S W, Cahen, D L, Buschow, S I, Fuhler, G M, Peppelenbosch, M P & Bruno, M J 2022, 'Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival', Frontiers in medicine, vol. 8, 751110, pp. 1-7. https://doi.org/10.3389/fmed.2021.751110